WallStreetZenWallStreetZen

NYSE: NVTA
Invitae Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NVTA

Based on 2 analysts offering 12 month price targets for Invitae Corp.
Min Forecast
$0.50-25.37%
Avg Forecast
$0.75+11.94%
Max Forecast
$1.00+49.25%

Should I buy or sell NVTA stock?

Based on 2 analysts offering ratings for Invitae Corp.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
2 analysts 100%

Be the first to know when Wall Street analysts revise their NVTA stock forecasts and price targets.

NVTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Top 23%
78
Strong SellMaintains$0.50-25.37%2023-08-15
Goldman Sachs
Bottom 4%
4
Strong SellMaintains$1.00+49.25%2023-07-24

1 of 1

Forecast return on equity

Is NVTA forecast to generate an efficient return?

Forecast return on assets

Is NVTA forecast to generate an efficient return on assets?
Company
-23.14%
Industry
11.23%
NVTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NVTA revenue growth forecast

How is NVTA forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
5.94%
Industry
5.32%
Market
11.91%
NVTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVTA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NVTA$0.67$0.75+11.94%Strong Sell
LAB$2.78$4.00+43.88%Strong Buy
BDSX$1.47N/AN/A
FONR$15.96N/AN/A
BNR$0.99N/AN/A
View Top Diagnostic & Research Stocks

Invitae Stock Forecast FAQ

Is Invitae Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: NVTA) stock is to Strong Sell NVTA stock.

Out of 2 analysts, 0 (0%) are recommending NVTA as a Strong Buy, 0 (0%) are recommending NVTA as a Buy, 0 (0%) are recommending NVTA as a Hold, 0 (0%) are recommending NVTA as a Sell, and 2 (100%) are recommending NVTA as a Strong Sell.

If you're new to stock investing, here's how to buy Invitae stock.

What is NVTA's forecast return on equity (ROE) for 2023-2024?

(NYSE: NVTA) forecast ROE is N/A, which is considered weak.

What is NVTA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NVTA price target, the average NVTA price target is $0.75, with the highest NVTA stock price forecast at $1.00 and the lowest NVTA stock price forecast at $0.50.

On average, Wall Street analysts predict that Invitae's share price could reach $0.75 by Aug 15, 2024. The average Invitae stock price prediction forecasts a potential upside of 11.94% from the current NVTA share price of $0.67.

What is NVTA's forecast return on assets (ROA) for 2023-2024?

(NYSE: NVTA) forecast ROA is -23.14%, which is lower than the forecast US Diagnostics & Research industry average of 11.23%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.